NanoString™ Technologies is developing a patent pending nanotechnology based platform for single molecule identification and digital quantification. The NanoString™ system uniquely barcodes individual target molecules, scans them, and delivers a literal inventory of target molecules in the biological sample. This cutting-edge technology is a truly broadbased platform onto which many applications can be developed, in life sciences or other industries entirely. Applications include gene expression analysis, proteomics, molecular diagnostics and, in the future, predictive, preventative, and personalized medicine.
The NanoString technology was invented at the Institute for Systems Biology (ISB) in the lab of Dr. Leroy Hood in 2000. The company was spun out of the ISB in 2003 when the technology was exclusively licensed to NanoString Technologies. As of April 2005, NanoString Technologies has raised more than $8 million from OVP Venture Partners of Kirkland, WA and Draper Fisher Jurvetson of Menlo Park, CA. Chad Waite of OVP and Jennifer Fonstad of DFJ both sit on the board of directors of NanoString along with Perry Fell, NanoString’s CEO. NanoString Technologies is located on the Elliott Bay waterfront in Seattle, WA and has 19 employees.
NanoString Completes Issuance of $15.3 Million Series E Preferred Stock
NanoString Unveils Three Assay Kits for nCounter Analysis System
NanoString Announces Availability of nCounter Rat miRNA Expression Assay Kit
NanoString Announces First Fixed-Panel Assay Product
NanoString Secures License to Develop In Vitro Diagnostic Products for Breast Cancer
Researchers Detect Genetic Copy Number Variations Using Novel Solution from NanoString
Researchers Can Now Directly Profile up to 800 Transcripts in a Single Tube
NanoString Releases Early Access Program for New nCounter Custom CNV Assays
NanoString Receives ISO 13485:2003 Certification for nCounter Analysis System
New Assay Kit from NanoString for miRNA Analysis
NanoString Announces Collaboration with Broad Institute of MIT and Harvard
NCI Employs NanoString nCounter Analysis System at its Core Labs
Financing Allows NanoString to Accelerate Commercialization of nCounter Analysis System
Ping Wang, Ph.D.
We speak with researchers behind the latest advancement in graphene hBN research that could boost the development of next-generation electronic and quantum devices.
Dr. Laurene Tetard
AZoNano speaks with Dr. Laurene Tetard from the University of Central Florida about her upcoming research into the development of nanotechnology that can detect animal-borne diseases. The hope is that such technology can be used to help rapidly control infected mosquito populations to protect public
Dr. Amir Sheikhi
AZoNano speaks with Dr. Amir Sheikhi from Pennsylvania State University about his research into creating a new group of nanomaterials designed to capture chemotherapy drugs before they impact healthy tissue, amending a fault traditionally associated with conventional nanoparticles.
The Filmetrics R54 advanced sheet resistance mapping tool for semiconductor and compound semiconductor wafers.
This product profile describes the latest nano-particle analyzer "thesis particle size analyzer" and its key
The Filmetrics F40 turns your benchtop microscope into an instrument for measuring thickness and refractive index.